Clinical Trial Update: Sac-TMT Plus Bevacizumab as Second-Line Treatment for Advanced Non-Squamous Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Sac-TMT in combination with bevacizumab as second-line treatment for advanced non-squamous non-small cell lung cancer. The study is not…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Avastin (bevacizumab)
• Sac-TMT

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Lung Cancer | Phase 2 | Status: NOT_YET_RECRUITING